Tuesday, September 22, 2020 12:41:09 PM
If through the help of people like EVONTEK, an advanced version becomes available, then they can apply for a full patent right then and there!
Then they have the U-of-Michigan working on a NEW Chemistry for the CHS, that is my hope at least, so they can, theoretically speaking, develop two different versions of the CHS? If they come up with something new as well, then we can apply for two Patents, one for each version of the product?
But again, this area of Investment is the most difficult one to deal with? There are so many fine products gathering dust somewhere because the competition is often 5 steps ahead of the sub-penny Co's? It is like the old New York Yankees playing a 10 game series with a good Minor league team! After a long series, where the Yankees won 9 of the games easily, the minor league team won 1 game after fighting tooth and nail for nine innings, and edged-out the Yanks due to an error in the Ninth inning! Usually it is the other way around because the minor league team usually makes the most errors!
There is hope though, as the guys at the top are very very energetic, (how can they not be when they work only 7-8 days a month,) so they can often overcome a deficit through sheer determination and energy!!! GL
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM